Three pathways, not one — commercialising enabling process IP for a high-volume materials sector
A commercial viability assessment commissioned by a UK university enterprise office. The strategy reframed the commercialisation question from single spinout to three pathways in parallel — and identified manufacturing scrap, not end-of-life feedstock, as the fastest route to commercial traction.
The starting position
A UK university enterprise office approached the engagement with a process technology that had reached strong technical performance in the lab. The IP demonstrated reproducible separation across multiple feedstock variants and across the chemistries that dominate the application sector. Benchmark data showed near-complete separation efficiency at an order of magnitude lower energy than the incumbent chemical and thermal routes, and at a cost per tonne that compared favourably with the incumbent mechanical alternatives. The technology was credibly differentiated.
What the University did not yet have was a defensible commercial articulation. The application sector is a crowded narrative. Large-scale chemical processing players dominate the public conversation. Adjacent direct-recovery routes are emerging but unproven at scale. Equipment manufacturers are increasingly bundled into turnkey contracts that take years to break into. Within that landscape it was not obvious which buyer archetype would adopt the technology first, at what price point, or through what commercial form. A single-spinout narrative was under active consideration, but without a grounded view of adopter readiness, market sizing, and competitive positioning, the spinout framing was premature.
The University needed an external commercial assessment: a market view built from the bottom up, a competitive landscape mapped against where the technology actually competes, and a recommendation on commercial form that respected the technology’s structural strengths rather than the institutional default.
What we did
The engagement was scoped and contracted as a paid commercial viability and market engagement assessment, conducted in collaboration with the academic lead on the underlying research programme. The work was anchored on three connected questions: how large is the addressable market, where does the technology sit against the competition, and what commercial form will move fastest into revenue.
Bottom-up market modelling. We built the market model from the production end of the value chain inwards, starting from the manufacturing capacity that the application sector already operates and is committed to expanding. From there we sized the total addressable market across the broader recovery sector, the serviceable addressable market for the segments where the technology’s strengths apply directly, and the serviceable obtainable market on early-stage adoption assumptions. A separate equipment-integration track, modelled against capital-equipment budgets in the application sector, contributed a further serviceable opportunity. The two together established the portfolio-scale commercial opportunity.
Competitive benchmarking. We mapped the technology against the three incumbent processing routes — chemical, thermal, and mechanical — on cost per tonne, energy per tonne, output purity, and carbon footprint. The technology delivered a four-axis advantage that no incumbent could match on any single axis, let alone all four. That benchmarking is what anchored the commercial narrative for every adopter conversation downstream.
Adopter segmentation. We mapped four candidate adopter segments — incumbent chemical-route processors, direct-recovery operators, capital-equipment manufacturers serving the production sector, and producers running internal scrap operations. For each segment we characterised where the technology competes head-on versus where it slots in as a complementary upstream process. The four segments move on different procurement clocks and respond to different commercial forms — that distinction shaped the pathway recommendation.
Commercialisation pathway analysis. Rather than recommend a single commercial form, we tested three in parallel: process licensing to existing operators, direct sale of modular equipment through established line integrators, and joint ventures with producers running high-scrap-rate ramp operations. For each pathway we set out adopter readiness, deal-size expectations, technical integration demands, and the conditions under which each pathway outperforms the others.
Regulatory and sustainability framing. We anchored the commercial narrative in the regulatory pull. Sustainability and critical-materials policy in both the EU and US is moving toward compliance regimes that reward low-energy, low-solvent, traceability-friendly processing — exactly the conditions that favour the technology. The regulatory framing identified the EU and US as the commercially receptive first-beachhead markets and informed the geographic prioritisation in the pathway recommendation.
The commercial move
Two reframes carried the commercial recommendation.
The first reframe was the priority feedstock. The public narrative for this application sector is dominated by end-of-life material — the volumes projected to arrive in the late 2020s and 2030s as installed assets reach the end of their service life. Those volumes will eventually be the largest market. They are not the market that generates the first commercial contract. Manufacturing scrap is generated continuously inside production facilities, co-located with the production equipment, homogeneous in composition per line, and known-chemistry — a feedstock profile that is cleaner to process than the mixed-composition end-of-life streams the public conversation is built around. For a process whose structural advantage is purity and binder-agnostic separation, the manufacturing-scrap stream is the one that rewards the technology’s strengths most directly. End-of-life remains a valid long-term market. It is not the market that generates first revenue.
The second reframe was the commercial form. A single-spinout posture would force the technology to compete on terms that do not match its strengths. The technology is enabling process IP. Its natural commercial form is enabling-IP commercialisation: licensed into operators who already have the customer relationships and the scale, sold as modular equipment by integrators who already have the procurement frameworks, and joint-ventured with producers whose internal scrap economics make co-development the right deal structure. None of these forms is the right answer alone. Three in parallel — license, sell, JV — is.
Two consequences follow.
Premature exclusivity commitments on any one pathway would foreclose options the technology does not yet need to close. The three pathways are not mutually exclusive. They run concurrently, with resource allocation shaped by which route generates contracted traction first.
And the institutional default — single spinout — is not always the right answer for enabling process IP that sits upstream of a mature industrial value chain. The honest answer is harder to arrive at without grounded market work, but it is the answer that respects the technology’s structural strengths.
What the engagement produced
- A bottom-up market model with defensible total, serviceable, and obtainable market figures, plus a separate equipment-integration track with its own serviceable opportunity sized against capital-equipment budgets.
- A competitive benchmarking matrix comparing the technology against incumbent chemical, thermal, and mechanical routes on cost, energy, purity, and carbon footprint.
- A four-segment adopter map covering incumbent processors, direct-recovery operators, capital-equipment manufacturers, and producers with internal scrap operations — with the entry point identified per segment.
- Three commercialisation pathways evaluated in parallel — process licensing, equipment supply, and joint venture — with adopter readiness, deal-size expectations, and integration demand for each.
- A regulatory-pull narrative anchored in EU and US sustainability and critical-materials policy, with first-beachhead geographic prioritisation.
- A risk register covering industrial conservatism, line integration, process safety, feedstock format variability, contamination, regulatory compliance, IP and freedom-to-operate, and scale-up.
- A recommendation against single-spinout framing, in favour of an enabling-IP posture that supports licensing, equipment supply, and JV routes concurrently — with manufacturing scrap identified as the fastest revenue feedstock ahead of end-of-life material.
Why it matters
The general-purpose observation is that the institutional default — a new spinout — is not always the right commercial form for enabling process IP that sits upstream of a mature industrial value chain.
University technology programmes routinely face a narrative forced on them before the evidence justifies it. Spinouts are visible, fundable, and celebrated. They are also slow to revenue, expensive to capitalise, and structurally mismatched to enabling IP whose value lies in being adopted into other people’s products and processes rather than in carrying a standalone company. The more honest answer — that the technology should enter the market as enabling IP, through multiple commercial forms in parallel, against the feedstock that pays first — is the harder answer to arrive at without grounded market work.
The broader point is structural. In sectors where industrial volumes are growing fast and the public narrative focuses on the end-of-life half of the value chain, the economics that fund the next decade of infrastructure build-out are often being generated now, on the production side, by waste streams that grow with manufacturing capacity rather than with installed asset retirement. Technologies that can attach themselves to that cash flow — without waiting for end-of-life volumes to arrive — have a measurable commercial advantage. That observation is not unique to one engagement. It is the observation any commercialisation case for an enabling process technology should be built around.
For a research group with credible enabling IP, the discipline is to refuse the institutional default, do the market work that surfaces the multiple commercial forms the technology can support, and let the form that generates contracted traction first pull the others into focus.
A note on status
The engagement is complete and the strategy is delivered. The commercialisation recommendations are with the University for execution. Specific adopter engagements, deal postures, and counterparty detail remain commercially confidential. This case study describes Hatch Oxford’s methodology at the level it can be discussed publicly. The client, the technology, the application sector, the specific findings, and any counterparties are not identified.
